News
Biovac launches state-of-the-art R&D lab
07 Nov 2025
SA manufacturer Biovac launched a new state-of-the-art development laboratory at its Pinelands, Cape Town facility, reported
Business Day (7 Nov 2025)
“This will enable scientists to develop vaccines for routine immunisation programmes and to create shots used to combat disease outbreaks.
The new lab is the final step toward full, end-to-end production to end Africa's severe dependency on foreign-made vaccines.
“Currently, Africa imports an estimated 99% of its required doses, a vulnerability that was starkly exposed during the COVID-19 pandemic when African nations were left at the back of the queue for supplies.”
[BACK TO NEWS]